【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001140361-22-004285 Act: 34 Size: 60 KB 网页链接
$Neuronetics(STIM)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000834237-22-007320 Act: 34 Size: 13 KB 网页链接
$Neuronetics(STIM)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-22-000583 Act: 34 Size: 59 KB 网页链接
$Neuronetics(STIM)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000905718-22-000139 Act: 34 Size: 30 KB 网页链接
$Neuronetics(STIM)$ 内部交易: 2022-01-24,CFO,Furlong Stephen ,卖出,268普通股, $3.40
$Neuronetics(STIM)$ 内部交易: 2022-01-21,CFO,Furlong Stephen ,卖出,17189普通股, $3.62
$Neuronetics(STIM)$ 内部交易: 2022-01-24,Sr. VP, GC, CCO and Secretary,MACAN WILLIAM ANDREW ,卖出,11562普通股, $3.52
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-22-001537 Size: 6 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-22-001538 Size: 5 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-22-000163 Act: 34 Size: 174 KB 网页链接